TrialBMC cancer2019
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma.
Seok Jin Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
TrialBMC cancer2019
Seok Jin Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.